ABVC
ABVC BioPharma, Inc.
Biotechnology · Healthcare · United States
1.00
close · 2026-10-30
value
31
cheaper than peers31
quality
20
stronger fundamentals20
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 1 year ago | -6.8% | 67 |
| cash flow yield, latest year | -11.2% | 63 |
| price to book | 2.48× | 48 |
| cash flow yield, 2 years ago | -15.8% | 48 |
| earnings yield, 1 year ago | -42.0% | 45 |
| earnings yield, latest year | -39.0% | 41 |
| cash flow yield, 3 years ago | -28.2% | 34 |
| earnings yield, 2 years ago | -180.0% | 20 |
| earnings yield, 3 years ago | -520.0% | 2 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -87.8% | 31 |
| debt to equity | 21.3% | 24 |
3 of 4 measures available
Facts
| market cap | $27M |
| free cash flow | $1.2M |
| employees | 16 |
| first trade | 2004-11-10 |
| next earnings | not reported |
| fundamentals updated | 2026-08-13 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.39 | -0.42 | -1.80 | -5.20 |
| free cash flow | -$3.0M | -$1.8M | -$4.2M | -$7.5M |
| net income | -$7.9M | -$4.9M | -$7.8M | -$16.4M |
| revenue | $0 | $509,589 | $152,430 | $969,783 |
| unusual items | -$1.1M | -$108,714 | -$199,198 | -$377,034 |